Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Sep 1;17(9):e0273622. doi: 10.1371/journal.pone.0273622

It’s made a really hard situation even more difficult: The impact of COVID-19 on families of children with chronic illness

Jordana McLoone 1,2,*, Claire E Wakefield 1,2, Glenn M Marshall 3, Kristine Pierce 1, Adam Jaffe 1,4, Ann Bye 1, Sean E Kennedy 1,5, Donna Drew 3, Raghu Lingam 1
Editor: Stephane Shepherd6
PMCID: PMC9436103  PMID: 36048846

Abstract

Objective

For over two years, the global COVID-19 pandemic has forced major transformations on health, social, and educational systems, with concomitant impacts on mental health. This study aimed to understand the unique and additional challenges faced by children with chronic illness and their families during the COVID-19 era.

Method

Parents of children receiving treatment for a chronic illness within the neurology, cancer, renal and respiratory clinics of Sydney Children’s Hospital were invited to participate. We used qualitative methodology, including a semi-structured interview guide, verbatim transcription, and thematic analysis supported by QSR NVivo.

Results

Thirteen parents of children receiving tertiary-level care, for nine chronic illnesses, participated. Parents reported intense fears relating to their ill child’s additional vulnerabilities, which included their risk of developing severe COVID-19 disease and the potential impact of COVID-19-related disruptions to accessing clinical care, medications, allied health support and daily care protocols should their parent contract COVID-19. Parents perceived telehealth as a highly convenient and preferred method for ongoing management of less complex healthcare needs. Parents reported that the accrual of additional stressors and responsibilities during the pandemic, experienced in combination with restricted social interaction and reduced access to usual support networks was detrimental to their own mental health. Hospital-based visitation restrictions reduced emotional support, coping, and resilience for both parents and children and in some cases led to marital discord, sibling distress, and financial loss. Supportive factors included increased time spent together at home during the pandemic and improved hygiene practices at school, which dramatically reduced the incidence of non-COVID-19-related communicable illnesses in chronically ill children.

Discussion

For families caring for a chronically ill child, COVID-19 made a difficult situation harder. The pandemic has highlighted the need for targeted psychosocial intervention for vulnerable families, to mitigate current mental health burden and prevent chronic psychological distress.

Introduction

Globally, COVID-19 has caused disruptions to the clinical management of chronic childhood illnesses, including reduced access to screening, diagnostic and therapeutic services, surgery, essential medications, and follow-up surveillance [14]. Arising in parallel with the medical challenges of the pandemic are immense changes to the social landscape. The lifestyle and needs of the child, including education and peer interactions, have been curbed by social isolation and school closures [58]. For children with a chronic illness, who already face a disproportionate level of psychosocial burden [9], it is expected that this confluence of factors may result in additional consequences compared to the general population [10].

Across childhood chronic illnesses, parents fill gaps in fragmented and uncoordinated healthcare systems, functioning as case managers, medical record keepers, and patient advocates. The pandemic required parents to rapidly navigate their child’s new care pathways, as health systems became overwhelmed and healthcare delivery models pivoted to telehealth and virtual care [11, 12]. Simultaneously, workplaces and schools also transitioned to virtual sites, with little time for planning, piloting, or training. Up-skilling to new work platforms, procedures, and home-learning responsibilities, while caring for a chronically ill child, is likely to have placed parents under unprecedented levels of pressure. Not surprisingly, emerging evidence indicates that parents of children with underlying health conditions have been experiencing greater stress than parents of healthy children during the pandemic [13, 14].

Given the vital role families play in the health of children with chronic illness, a deeper understanding of their pandemic experiences is needed to ensure that evidence-based research guides decision-makers as they rapidly develop and deploy new services, and also re-imagine what a return to a new normal might look like for child healthcare services. This study therefore explored the impact of COVID-19 on families of children with chronic illness.

Method

We used an explorative, qualitative methodology to obtain nuanced insights into the experiences of children with chronic illness and their families during the COVID-19 pandemic. We first conducted a narrative literature review of the emerging literature on COVID-19 and its impact on children with disability or illness. This review was guided by the Economic and Social Research Council framework [15] and we presented this to a multidisciplinary panel, including five pediatric specialists, a behavioral scientist, and a parent consumer. The expert panel reviewed the literature and discussed the potential issues relevant to children with chronic illness in the context of the pandemic and developed a semi-structured interview guide through an iterative process. The final interview guide explored families’ experiences of the COVID-19 pandemic and how their access to medical care, education, and social support had been impacted. The interview also explored the mental health impact of caring for a chronically ill child during a pandemic, as well as the mental health impacts for other family members, including the child with chronic illness and their sibling(s). At the conclusion of the interview we collected demographic items (e.g. age and sex of each family member).

First author JM (PhD), who has over a decade of qualitative research experience, interviewed families between November, 2020 and September, 2021. We audio-recorded interviews, which were professionally transcribed verbatim. We organized coded passages into themes and analysis was guided by the Braun and Clarke approach [16]. We used QSR NVivo 12 software to support data coding and analysis [17]. We used the COREQ [18] checklist to promote accurate reporting of qualitative studies. The Sydney Children’s Hospital Network ethics board granted ethical approval (2020/ETH02027).

Sample

We invited parents of children who a) were currently less than 16 years of age, b) had received treatment at Sydney Children’s Hospital (SCH) within the past year, and c) were diagnosed with a chronic illness (a persistent illness requiring long term management), to participate in the study. SCH clinics including neurology, renal, respiratory and cancer, were asked to provide the contact details of families who met the study’s eligibility criteria and were also purposively selected to provide a range of experiences, including recently diagnosed/long term patients, urban/rural, and severe/moderate disease. We sent families an invitation letter and consent form via mail and telephoned two weeks later to further explain the study and confirm whether or not a parent was interested in participating.

COVID-19 context

The COVID-19 context in which these interviews were conducted was as follows. Sydney Children’s Hospital is located in the Australian state of New South Wales (NSW). NSW has a population of over 8 million residents, yet between 1 January 2020 and 1 June 2021, reported only 5,587 cases of COVID-19. There were 54 deaths during this period, with 13 of these deaths occurring outside of aged care services [19]. For many months, there were zero to few cases of community transmission. Schools were “closed” for approximately six weeks, however the children of essential workers continued to be allowed to attend school during this period.

Results

Thirty families were invited to participate. Of these, 13 mothers participated (43% response rate), see Table 1. Interviews were, on average, 42 minutes in length (range: 17–61 minutes). Five major themes were identified; COVID-19 specific concerns and impacts on medical care, mental health, support, and education. These themes are explored in detail below and illustrated in Fig 1.

Table 1. Participant demographic characteristics.

Participant characteristic N = 13
Parent sex, n(%) 13 female (100%)
Parent age, mean (range) 42.3 years (range: 36–52 years)
Sex of child with chronic illness, n(%) 61.5% male
Age of child with chronic illness, mean (range) 8.5 years (range: 4–16 years)
Number of siblings of child with chronic illness, mean (range) 1.8 siblings (range: 1–7)
Sibling age, mean (range) 12.5 years (range: 0–24 years)
Chronic illness diagnosis* Cancer
 Pre B Acute Lymphoblastic Leukemia
 Acute Lymphoblastic Leukemia
 Acute Lymphoblastic Leukemia
 Rhabdomyosarcoma
Renal
 Nephrotic syndrome
 Posterior urethral valves
 End stage kidney failure
 Mid-aortic syndrome
Neurology
 Epilepsy
 Epilepsy (neuronal migration disorder)
 Epilepsy (cortical dysplasia)
Other
 Cerebral Palsy
 Severe asthma
 Bronchiectesis
 Dextrocardia situs inversus

* Some children were diagnosed with multiple chronic illnesses and as such, more than 13 illnesses are reported.

Fig 1. Complexity diagram representing the inter-relatedness of factors impacting families of children with chronic illness during the COVID-19 pandemic.

Fig 1

COVID-19 specific concerns

Parents reported that the pandemic had been a highly stressful period and described how, for their families, the pandemic stress was borne in addition to multiple other stressors. “I mean things are already stressful in this house—a new baby and a chronically ill kid and you throw in COVID and job loss …things were intense a lot here. (ID 09, child with end stage kidney failure).

Parents of chronically ill children reported general feelings of uncertainty and fear, as well as fears unique to their child’s chronic health condition. “I was terrified at the beginning of the pandemic. I just thought every time [my son] gets a cold he ends up in the hospital and I just thought I don’t wanna think about what will happen if he gets this! (ID 06, child with severe asthma). Parents’ fears were typically intensified by extreme worries that the virus might have a greater impact on their chronically ill child, relative to children without chronic illness. “I’ve watched her crash and go to ICU. You know what a virus can do. (ID 10, child with epilepsy). Parents of chronically ill children often reported taking precautions and self-restricting movement beyond what the Australian public health guidelines recommended and continued to do so during periods when there were no, or very few (<10), community cases in the state. “I didn’t go to the shops until Monday [December]. I hadn’t been out like from February. (ID 09, child with end stage kidney failure).

Parents’ fears centered on what might happen to their child if they became ill and could not support the daily medical needs of their child (see S1 Table for extended quotes). Parents worried that should a member of the family contract COVID-19, their child’s chronic illness-related treatment would be postponed until the family completed their mandatory home-isolation period. “That was my major anxiety last year, that one of us would get COVID and that would jeopardise his treatment. So that was my biggest concern. (ID 02, child with rhabdomyosarcoma). Families also reported fears that medical supplies might be disrupted during the pandemic. “Because we rely on so many things to keep our little girl alive, I was definitely scared that things like that would be impacted. (ID 09, child with end stage kidney failure) and in 2021, when the Delta strain caused case numbers to surge, parents were fearful that there would not be sufficient hospital beds available for their chronically ill child. “I’m concerned if they [can] proceed with surgery that the beds will all be filled with anti-vaxxers and cases of COVID. (ID 13, child with epilepsy (cortical dysplasia))

In terms of the emerging COVID-19 vaccines, some parents were concerned that there may be insufficient trialing of the vaccine in children with rare diseases, with potentially unknown risks. “I am also worried about vaccination because [my daughter] has a chronic illness. Like, is it going to be tested enough on people like that? (ID 09, child with end stage kidney failure).

COVID-19 interruptions to medical care

Despite many challenges and disruptions, many families reported that their child’s acute care continued uninterrupted, and that telehealth had supported ongoing virtual clinics and communication between families of children with chronic illness and hospital clinicians. Many families felt that communication with their team had not been disrupted. “The hospital team’s been really supportive through it all. Always really impressed—we’ve been able to get onto them and everyone’s been really informative. (ID 10, child with epilepsy)

In terms of the ongoing management of chronic illnesses, some parents reported that clinics had been cancelled, “I think they cancelled all eye clinic reviews for us for nearly a year. (ID 10, child with epilepsy). In addition, certain medications had not been available at the hospital pharmacy. “I get a phone call from pharmacy and she goes, “Look, you can’t take all the medication because you know, with COVID, we have a shortage. (ID 12, child with Dextrocardia situs inversus). There were also considerable delays reported regarding critical scans and surgeries. “He actually needed surgery again but because of COVID …it was delayed for a long time. He was getting quite unwell and we just had to wait. (ID 08, child with mid-aortic syndrome)

Some families were burdened with the difficult decision of deciding whether or not to proceed with surgery, weighing the potential risks (exposure to COVID-19 within the hospital) and benefits (of surgery) for their child. Delays to surgery were often beyond the control of families and caused significant anxiety among parents, as they watched their child’s health deteriorate. In addition, surgical delays often resulted in other developmental losses for young children, “Huge worries about the future. [For] a 5 year old, a 6 months’ delay [to surgery] is a huge portion of their life and it’s such formative years in terms of their developmental opportunities. (ID 13, child with epilepsy (cortical dysplasia)). For some children, accessing potentially life-altering surgery at centers of excellence remained uncertain due to the closure of state borders.

Clinicians used videoconferencing platforms to conduct virtual clinics, which were perceived as easy to use and highly convenient “There are times [my daughter] might just not be feeling great, or we are worried because it’s winter …so we just do telehealth. (ID 09, child with end stage kidney failure). The convenience of virtual clinics also included reducing travel burden, eliminating travel sickness, and fitting around other family commitments, for example, the schedules of a newborn baby. “It’s nice not having to drive from Canberra to Sydney [3-hour drive], as I had a little baby. (ID 09, child with end stage kidney failure). Telehealth was seen as a tool that would also greatly benefit rural and regional families “I think for regionally based people telehealth is great. (ID 07, child with posterior urethral valves) and enhance interstate collaborations. Telehealth also supported the continuation of allied health services throughout the pandemic and families reported that this was convenient in many ways. “The use of technology was forced upon everyone pretty quickly, but it certainly has its benefits. (ID 07, child with posterior urethral valves).

Families of children with chronic illness reported that their general practitioner’s (GP) use of telehealth was telephone-based (video-conferencing was not available) and that this this was the preferred method for low-risk, or ongoing management, for example, “If it’s something little that can be done over the phone, like a script or something” (ID 03, child with nephrotic syndrome). Avoiding the contagion risks associated with the GP waiting room was also noted as a benefit of care provided via telehealth. “I prefer not to take myself to a GP and risk catching something that I could give to [my chronically ill son] if I don’t have to. So [I prefer] not taking my daughter there, or myself. (ID 04, child with acute lymphoblastic leukemia). Also, for families whose child was wheelchair bound, or who were less mobile due to their child’s chronic illness, telehealth with the GP was preferred. “So it’s made it so much easier, it’s brilliant actually it’s made life 100% better. (ID 01, child with cerebral palsy)

Given the convenience of telehealth, many families hoped that it would remain available as an option after the pandemic was over and cited advances in providing care remotely as a silver lining of the pandemic. The increased availability of and access to care that telehealth offers rural and remote families was also discussed. “If we lived in a regional area [telehealth] would make a huge difference to accessing treatment. (ID 13, child with epilepsy (cortical dysplasia)).

The impact of COVID-19 interruptions on mental health

Some families reported that they had been coping well during the pandemic. Protective factors included higher resilience among families with a chronically ill child relative to other families, learning about self-care during earlier waves of the pandemic, and utilizing virtual support groups. “I think there is a certain amount of resilience and adaptability that you have when you’ve got a child with a chronic illness. (ID 06, child with severe asthma). Many families reported that the ways in which the pandemic had forced them to slow down, limit extracurricular activities, and spend more time together as a family, had been beneficial. “We were happy with just the four of us and our little family for a while. (ID 03, child with nephrotic syndrome)

Parents recognized how important their own mental health was during this difficult time, as they needed to stay strong for their sick child. “I’ve got an added responsibility to manage my feelings… I don’t want to impact his situation [and make it] more difficult because I’m not managing how I feel. (ID 13, child with epilepsy (cortical dysplasia)). Parents noted that they were having to manage their own mental health needs as they journeyed through their child’s illness path,

The main thing that I’ve struggled with is sitting with the current uncertainty and trying to hold hope but also prepare myself for the possibility that it’s not treatable. I feel more despair and more hopelessness. Looking after [my son] I guess I’ve got an added responsibility to manage my feelings. I don’t want to impact his situation and make it more difficult because I’m not managing how I feel. (ID 13, child with epilepsy)

This was in addition to the needs of their chronically ill child “It’s a bit of a rollercoaster ride with her, still she’s just sad. (ID 10, child with epilepsy), and siblings’ mental health too, “he’s ended up with a bit of ongoing anxiety since lockdown; which we are still dealing with now. (ID 06, child with severe asthma).

Mothers recognized how much strain they had experienced to support others in the family, especially under circumstances that saw them also juggling multiple practical roles. Many mothers reported limited support for themselves, including not being able to see, or physically touch their friends during the most difficult times. “When you’re upset or something terrible happens you would hug your friends. …I stopped that altogether. (ID 11, child with acute lymphoblastic leukemia). Some mothers reported that it had been difficult to lose their supportive work environment during this time and missed the reprieve that their career experiences gave them in a face-to-face work environment.

While some parents reported that they were aware that excellent support for their child was available via their child’s hospital psychologist and social worker, “I’ve spoken to [the clinical psychologist] a few times and she’s amazing. (ID 05, child with pre B acute lymphoblastic leukemia), others reported that there were barriers to receiving mental health support during the pandemic, especially in the community setting. The pandemic had increased the need for services, at a time when services were limited, causing a backlog in private mental health services and long waitlists.

Many families were separated by pandemic-restrictions and the negative impact of this was consistently reported. To limit COVID-19 transmission risk, the hospital implemented a ‘one-parent, no siblings’ rule for most months from March, 2020 onwards. While parents understood the hospital’s policy was aimed at protecting its patients and staff, they also felt this policy placed families at risk of mental health impacts as it limited the emotional support they could provide each other at critical times. Parents emphasized the importance of communicating well with each-other, especially during traumatic periods. Parents reported difficulty communicating their own emotional needs, as well as distressing and complex medical information to the second parent who was not allowed to enter the hospital.

Although parents were appreciative of the circumstance, they consistently emphasized the negative impact of siblings being unable to see each-other during hospital admissions. “I’d say that probably had the biggest impact on the family. (ID 11, child with acute lymphoblastic leukemia). Mothers of young siblings (e.g. breast-feeding infants) also found the experience to be distressing. “I’m breastfeeding and I’m always the one that stays with [my chronically ill daughter]; that actually stressed me out probably nearly more than anything. (ID 09, child with end stage kidney failure). Though a sibling exemption for breast-feeding infants was granted, allowing infants to accompany the mother in the hospital, infants were not allowed in the intensive care unit, causing additional stress and costs. Managing outpatient appointments was similarly reported as challenging for families with young children, from both a practical and financial perspective.

The impact of COVID-19 on support for families of children with chronic illness

Families of children with a chronic illness reported that they typically sought support from extended family, however risks and restrictions during the pandemic meant that this was often not possible. Community organizations were also reported as a vital support network for families. Unfortunately, many were limited in their capacity during the pandemic. The loss of charity funded accommodation, as well as social and psychological support, was keenly felt. Social support was reported as integral to well-being, with parents discussing how their local community, comprised of families of children without a chronic illness, suddenly became more understanding of what it was like to live with ongoing uncertainty and fear for their child’s health. However, the valuable social support shared between families of children with a similar illness on the hospital wards was interrupted as many families tried to maintain social distancing and kitchens/communal areas were closed.

COVID-19 interruptions to education

Home-based-learning was seen as highly challenging during periods of school closures, with one mother stating, “I was literally ready to go ‘See you all later, I am never coming back’. It was that bad.(ID 12, child with Dextrocardia situs inversus). Families of children with a chronic illness also raised unique issues, such as worries that if they ceased home schooling and returned their child to school, the spread of COVID-19 through their child’s school might delay their child’s treatment or surgery. Some parents shared that they also kept siblings home even after schools were re-opened, potentially compromising their learning outcomes, due to fears that “catching something” would compromise the treatment protocols of their ill child.

Parents expressed that they felt the COVID-safe arrangements at the school, including not allowing parents on campus, meant that they were less able to communicate with teachers, resulting in missed feedback regarding their child’s educational needs, and medical symptoms. Parents shared that they felt guilty and reluctant to send their child with additional needs to school during “closures”, as schools had limited staff on campus.

Though parents often waited additional weeks before allowing their child to return to school after periods of closure, once most children had returned to school, the school stopped supporting home-based-learning leading to some parents feeling that their child was disadvantaged. However, other parents noted that the pandemic had actually helped their child who would not have been able to attend school due to illness, by increasing the availability of online learning platforms and resources. Some parents of chronically ill children also reported that they felt like they were better equipped to manage distance education than families of healthy children, due to past experiences.

Parents shared that they appreciated that schools and students were maintaining better cleaning and hygiene practices, and that children who were unwell or displaying any symptoms were discouraged from attending school. Parents noted that given these measures of prevention, their child had experienced fewer infections over the past several months with a notable positive impact on their health.

Discussion

Despite experiencing lower levels of COVID-19 than many other parts of the world, especially during 2020, disruptions to health, education and social support have had an acute psychosocial impact on Australian families of children with chronic illness. These themes of mental health impact, feelings of loneliness and isolation, and changes to organisations and policies shaped by COVID-19, have been similarly identified among other populations where COVID-19 was more prevalent and school closures more prolonged [20]. Adequately responding to and addressing the needs of families of children with chronic illness, as well as planning for the minimization of longer-term impacts om well-being is critical.

As hospitals rapidly reorganized in response to the developing pandemic, many clinics were temporarily closed and clinicians were challenged to find alternative ways to continue to provide treatment and care while maintaining social distancing practices. For most, embracing telehealth was the obvious solution and the rapid uptake of virtual care was supported by new videoconferencing platforms that patients and their families found easy to access and use [21]. Positive attitudes towards pediatric telehealth [22, 23] are supported by our current study findings, with telehealth perceived to be convenient and one of the pandemic’s “silver linings”, which families hoped would remain after COVID-19 had abated. New models of care that integrate telehealth need to be developed, superseding the current model of repeatedly delivering stand-alone instances of use (i.e. the stop-gap use model) [24, 25]. Comprehensive models that offer a number of services, increase in complexity as needed, and address needs from diagnosis to disease progression and long-term care are required. Such programs are beginning to emerge, including Contactless [26], which specifically addresses the care needs of pediatric patients with rare and chronic conditions, who typically need regular follow-up even in the absence of acute events. Contactless is a multimodal, multidisciplinary remote-care model with a modular framework allowing basic care, with escalation on need, up to the more accurate and complex levels of care [26].

While telehealth has the potential to offer convenient care, improve access for rural families, and increase equity by decreasing the costs associated with accessing care for patients, more comprehensive evidence is needed to demonstrate that the telehealth model of care is at least equivalent to face to face care in terms of health outcomes. Also, telehealth may not be appropriate for families closer to diagnosis, whose child’s management is still new, difficult, unfamiliar or fluctuating, and for families who are yet to establish a good working relationship with their clinical team. Special consideration of these newer families’ needs should be taken into account when designing care pathways that incorporate or rely on telehealth.

Sydney Children’s Hospital Network has reported a 55% increase in pediatric mental health presentations during the COVID-19 period [27]. The findings of this study confirm that there is a significant unmet need for psychosocial support among families of children with chronic illness. While this need most likely predated the pandemic, it is likely to have become stronger as stressors compound, services are stretched, and waitlists lengthen. This need for psychosocial support is reiterated in the emerging literature [1, 2831] and new scales, such as the ‘COVID-19 Family Stressor Scale’ have been developed to measure COVID-related disruption and psychological stress [32]. It is important to remember, as many countries re-establish unrestricted movement and confidence, that many families of children with chronic illness will continue to prioritize their child’s health over their family’s need to return to normal. Among a community already fatigued by multiple lockdowns and pandemic stress, these families may experience an extended period of stress, fear, restrictions and diminished social interaction. It is critical to acknowledge that families of children with chronic illness may have a disproportionately difficult experience relative to other groups. Ensuring that appropriate psychosocial support services are available to families of children with chronic illness is a critical part of our community’s roadmap out of the COVID-19 pandemic.

Families of children with chronic illness reported hospital visitation restrictions as one of the most challenging aspects of the pandemic, both practically and emotionally. During the pandemic, pediatric wards have been challenged with unique considerations in regards to visitation policies. While early evidence indicates visitor restriction is effective in preventing transmission of viruses within hospital settings [33], there are substantial complexities to be considered on pediatric wards. These include the dependence of young children on their parents for nutrition (e.g. breast feeding newborns), accomplishing daily-living tasks (e.g. dressing), decision-making (including medico-legal decisions), patient and parent education, and emotional comfort during traumatic illness and procedures.

Internationally, approximately 94% of North American hospitals with a pediatric ward, changed their visitor screening policy due to COVID-19 [34]. Though limiting visitors to children’s hospitals is consistent internationally, we call on researchers and clinicians to re-imagine infection control within a family-centered model of care [35] that will limit parent reported increases in stress, feelings of emotional isolation and decreased support, decreased medical communication, marital discord, sibling distress, financial stress, chronic sleep deprivation and career interruption. Additional psychosocial support to families on the wards should be provided until revised models of COVID-safe, family-centered care can be implemented.

Limitations

Our findings are based on the experiences of mothers only, with no fathers choosing to participate. Wade et. al. have shown that mothers have generally experienced greater COVID stress/disruption, distress, anxiety, and post-traumatic stress symptoms, compared to fathers. In the Wade et. al. study mothers’ higher COVID stress/disruption independently predicted all mental health outcomes, suggesting a stress accumulation model [36]. This is consistent with our finding that mothers reported one of the most difficult aspects of the pandemic was the “juggling act” that they had to perform. It is also possible that hospitals’ one-parent rule acts as a protective factor among fathers who, in this way, are shielded from distressing scenes of their child being ill, difficult conversations with medical professionals, and are not burdened by multiple responsibilities. Further research is needed to explore the experiences of fathers specifically.

This study is also limited to English speaking participants, recruited from a single site, and the recruitment of a small sample. Though the sample size of this study is small, sample adequacy in qualitative investigation relates to the appropriateness of the sample composition and size [37]. By purposively selecting families across a range of different diseases, ages, times since diagnosis, distances from the hospital and personal circumstances, the composition of this sample provides richly-textured and wide-ranging information relevant to the COVID-19 experience. Recent research has shown greater efficiency of purposive sampling (and accordingly lower sample size needs) compared to random sampling, as used in qualitative studies [38]. Furthermore, data saturation was observed within this sample, with no new themes reported within the last two interviews.

Conclusions

The pandemic has, and will likely continue to go through waves, as new variants develop. It is critical that we understand the challenges and needs of families with chronically ill children and prepare a health and education system that will meet these needs in the future. Key lessons learned during the COVID-19 era can also inform innovations that generalize beyond the pandemic, including the benefits of advanced telehealth for rural and unwell families, the importance of psychosocial and family-centered care.

Supporting information

S1 Table. The perceived impact of COVID-19—illustrative quotations of longer length.

(DOCX)

Data Availability

Data cannot be shared publicly in order to uphold the confidentiality of participants who have shared confidential medical information pertaining to children. In addition, we are restricted by the relevant ethics committee to not allow access to this data unless expressly named in the approved application. All requests for access to data can be made to either Jordana Mcloone (J.Mcloone@unsw.edu.au) or to the ethics committee, quoting the study reference number: 2020/ETH02434. The Sydney Children’s Hospital Network Human Research Ethics Committee (SCHN HREC) Email: SCHN-Ethics@health.nsw.gov.au Phone +612 9845 1253. Mail: ‘Research Ethics’ at the Sydney Children’s Hospital Network, Locked Bag 4001, Westmead, 2145, NSW, Australia.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Moreira DC, Millen GC, Sands S, Kearns PR, Hawkins DS. The Care of Children With Cancer During the COVID-19 Pandemic. American Society of Clinical Oncology Educational Book. 2021(41):e305–e14. [DOI] [PubMed] [Google Scholar]
  • 2.Tse Y, Darlington A-SE, Tyerman K, Wallace D, Pankhurst T, Chantziara S, et al. COVID-19: experiences of lockdown and support needs in children and young adults with kidney conditions. Pediatric Nephrology. 2021;36(9):2797–810. doi: 10.1007/s00467-021-05041-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Reilly C, Muggeridge A, Cross JH. The perceived impact of COVID-19 and associated restrictions on young people with epilepsy in the UK: Young people and caregiver survey. Seizure. 2021;85:111–4. doi: 10.1016/j.seizure.2020.12.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Boechat JL, Wandalsen GF, Kuschnir FC, Delgado L. COVID-19 and pediatric asthma: clinical and management challenges. International journal of environmental research and public health. 2021;18(3):1093. doi: 10.3390/ijerph18031093 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Azevedo JP, Hasan A, Goldemberg D, Geven K, Iqbal SA. Simulating the potential impacts of COVID-19 school closures on schooling and learning outcomes: A set of global estimates. The World Bank Research Observer. 2021;36(1):1–40. [Google Scholar]
  • 6.Engzell P, Frey A, Verhagen MD. Learning loss due to school closures during the COVID-19 pandemic. Proceedings of the National Academy of Sciences. 2021;118(17). doi: 10.1073/pnas.2022376118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Fontenelle-Tereshchuk D. Mental health and the COVID-19 crisis: The hopes and concerns for children as schools re-open. Interchange. 2021;52(1):1–16. doi: 10.1007/s10780-020-09413-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ye J. Pediatric mental and behavioral health in the period of quarantine and social distancing with COVID-19. JMIR pediatrics and parenting. 2020;3(2):e19867. doi: 10.2196/19867 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Mattson G, Kuo DZ, Yogman M, Baum R, Gambon TB, Lavin A, et al. Psychosocial factors in children and youth with special health care needs and their families. Pediatrics. 2019;143(1). doi: 10.1542/peds.2018-3171 [DOI] [PubMed] [Google Scholar]
  • 10.Serlachius A, Badawy SM, Thabrew H. Psychosocial challenges and opportunities for youth with chronic health conditions during the COVID-19 pandemic. JMIR Pediatrics and Parenting. 2020;3(2):e23057. doi: 10.2196/23057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Edge R, Meyers J, Tiernan G, Li Z, Schiavuzzi A, Chan P, et al. Cancer care disruption and reorganisation during the COVID-19 pandemic in Australia: A patient, carer and healthcare worker perspective. PLOS ONE. 2021;16(9):e0257420. doi: 10.1371/journal.pone.0257420 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Garfan S, Alamoodi AH, Zaidan BB, Al-Zobbi M, Hamid RA, Alwan JK, et al. Telehealth utilization during the Covid-19 pandemic: A systematic review. Computers in Biology and Medicine. 2021;138:104878. doi: 10.1016/j.compbiomed.2021.104878 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kostopoulou E, Sinopidis X, Gidaris D, Karantaglis N, Kassimos D, Gkentzi D, et al. Parents under siege: the psychological impact of COVID-19 outbreak on children’s caregivers. Swiss Medical Weekly. 2021(31). [DOI] [PubMed] [Google Scholar]
  • 14.Wimberly CE, Towry L, Caudill C, Johnston EE, Walsh KM. Impacts of COVID-19 on caregivers of childhood cancer survivors. Pediatric Blood & Cancer. 2021;68(4):e28943. doi: 10.1002/pbc.28943 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655. doi: 10.1136/bmj.a1655 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Clarke V, Braun V. Thematic analysis. Encyclopedia of critical psychology: Springer; 2014. p. 1947–52. [Google Scholar]
  • 17.QSR International Pty Ltd. (2020) NVivo (released in March 2020), https://www.qsrinternational.com/nvivo-qualitative-data-analysis-software/home.
  • 18.Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. International journal for quality in health care. 2007;19(6):349–57. doi: 10.1093/intqhc/mzm042 [DOI] [PubMed] [Google Scholar]
  • 19.Australian Government DoH. Coronavirus (COVID-19) at a glance for 30 June 2021. https://wwwhealthgovau/resources/publications/coronavirus-covid-19-at-a-glance-30-june-2021. 2021.
  • 20.Nicholas DB, Zulla RT, Conlon O, Dimitropoulos G, Urschel S, Rapoport A, et al. Mental health impacts of the COVID-19 pandemic on children with underlying health and disability issues, and their families and health care providers. Paediatrics & Child Health. 2022;27(Supplement_1):S33–S9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kenney LB, Vrooman LM, Lind ED, Brace-O’Neill J, Mulder JE, Nekhlyudov L, et al. Virtual visits as long-term follow-up care for childhood cancer survivors: Patient and provider satisfaction during the COVID-19 pandemic. Pediatric Blood & Cancer. 2021;68(6):e28927. doi: 10.1002/pbc.28927 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Rametta SC, Fridinger SE, Gonzalez AK, Xian J, Galer PD, Kaufman M, et al. Analyzing 2,589 child neurology telehealth encounters necessitated by the COVID-19 pandemic. Neurology. 2020;95(9):e1257–e66. doi: 10.1212/WNL.0000000000010010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Dahl-Popolizio S, Carpenter H, Coronado M, Popolizio NJ, Swanson C. Telehealth for the Provision of Occupational Therapy: Reflections on Experiences During the COVID-19 Pandemic. Int J Telerehabil. 2020;12(2):77–92. doi: 10.5195/ijt.2020.6328 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Camden C, Silva M. Pediatric Teleheath: Opportunities Created by the COVID-19 and Suggestions to Sustain Its Use to Support Families of Children with Disabilities. Physical & Occupational Therapy In Pediatrics. 2021;41(1):1–17. doi: 10.1080/01942638.2020.1825032 [DOI] [PubMed] [Google Scholar]
  • 25.Menon DU, Belcher HME. COVID-19 Pandemic Health Disparities and Pediatric Health Care—The Promise of Telehealth. JAMA Pediatrics. 2021;175(4):345–6. doi: 10.1001/jamapediatrics.2020.5097 [DOI] [PubMed] [Google Scholar]
  • 26.Mercuri E, Zampino G, Morsella A, Pane M, Onesimo R, Angioletti C, et al. Contactless: a new personalised telehealth model in chronic pediatric diseases and disability during the COVID-19 era. Italian Journal of Pediatrics. 2021;47(1):29. doi: 10.1186/s13052-021-00975-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hu N, Nassar N, Shrapnel J, Perkes I, Hodgins M, O’Leary F, et al. The impact of the COVID-19 pandemic on paediatric health service use within one year after the first pandemic outbreak in New South Wales Australia–a time series analysis. The Lancet Regional Health-Western Pacific. 2022;19:100311. doi: 10.1016/j.lanwpc.2021.100311 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Durcan G, Barut K, Haslak F, Doktur H, Yildiz M, Adrovic A, et al. Psychosocial and clinical effects of the COVID-19 pandemic in patients with childhood rheumatic diseases and their parents. Rheumatology International. 2021;41(3):575–83. doi: 10.1007/s00296-021-04790-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Correale C, Tondo I, Falamesca C, Capitello TG, Vigevano F, Specchio N, et al. Depression and anxiety in hospitalized children with epilepsy during COVID-19 pandemic: Preliminary findings of a cross-sectional study. European Psychiatry. 2021;64(S1):S670–S1. [Google Scholar]
  • 30.Farajzadeh A, Dehghanizadeh M, Maroufizadeh S, Amini M, Shamili A. Predictors of mental health among parents of children with cerebral palsy during the COVID-19 pandemic in Iran: A web-based cross-sectional study. Research in Developmental Disabilities. 2021;112:103890. doi: 10.1016/j.ridd.2021.103890 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Havermans T, Houben J, Vermeulen F, Boon M, Proesmans M, Lorent N, et al. The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients. Journal of Cystic Fibrosis. 2020;19(6):880–7. doi: 10.1016/j.jcf.2020.07.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Prime H, Wade M, May SS, Jenkins JM, Browne DT. The COVID-19 Family Stressor Scale: validation and measurement invariance in female and male caregivers. Frontiers in Psychiatry. 2021;12. doi: 10.3389/fpsyt.2021.669106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Washam M, Woltmann J, Ankrum A, Connelly B. Association of visitation policy and health care-acquired respiratory viral infections in hospitalized children. American journal of infection control. 2018;46(3):353–5. doi: 10.1016/j.ajic.2017.09.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kitano T, Piché-Renaud P-P, Groves HE, Streitenberger L, Freeman R, Science M. Visitor Restriction Policy on Pediatric Wards During Novel Coronavirus (COVID-19) Outbreak: A Survey Study Across North America. Journal of the Pediatric Infectious Diseases Society. 2020;9(6):766–8. doi: 10.1093/jpids/piaa126 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Goga A, Feucht U, Pillay S, Reubenson G, Jeena P, Madhi S, et al. Parental access to hospitalised children during infectious disease pandemics such as COVID-19. South African Medical Journal. 2021;111(2):100–5. doi: 10.7196/SAMJ.2021.v111i2.15388 [DOI] [PubMed] [Google Scholar]
  • 36.Wade M, Prime H, Johnson D, May SS, Jenkins JM, Browne DT. The disparate impact of COVID-19 on the mental health of female and male caregivers. Social Science & Medicine. 2021;275:113801. doi: 10.1016/j.socscimed.2021.113801 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Vasileiou K, Barnett J, Thorpe S, Young T. Characterising and justifying sample size sufficiency in interview-based studies: systematic analysis of qualitative health research over a 15-year period. BMC medical research methodology. 2018;18(1):1–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.van Rijnsoever FJ. (I Can’t Get No) Saturation: A simulation and guidelines for sample sizes in qualitative research. PloS one. 2017;12(7):e0181689. doi: 10.1371/journal.pone.0181689 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Stephane Shepherd

10 Jun 2022

PONE-D-22-14320It’s made a really hard situation even more difficult: The impact of COVID-19 on families of children with chronic illnessPLOS ONE

Dear Dr. McLoone,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 25 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Stephane Shepherd, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

"The authors acknowledge the support of the Maridulu Budyari Gumal, The Sydney Partnership for Health, Education, Research & Enterprise (SPHERE) Child Unlimited Clinical Academic Group; CEW is supported by the National Health and Medical Research Council of Australia (APP2008300)."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

"The author(s) received no specific funding for this work."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Thank you for your submission to PLOS ONE. The paper has now been reviewed by two experts in the field and I have also reviewed the paper.

Both reviewers recommended minor revisions. As such I invite you to respond to reviewer suggestions and re-submit your manuscript.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Strengths:

• This study characterizes the pandemic experiences and challenges of families of children with chronic illness, identifying the need for additional supports and value of telehealth for this high risk population in such circumstances. It provides a unique perspective of parents of children with chronic illness, who are often overlooked.

• Several strategies that are helpful for management of children with chronic care needs were identified that can be applied in future pandemic situations as well as for ongoing routine care.

• Qualitative methodology allowed for rich data collection. Saturation was achieved in identification of common themes.

• Well written and compelling paper.

Weaknesses:

• Relatively small sample size of 13 parents, although saturation was reached in exploring themes.

• Heterogeneity of chronic illnesses where different challenges may have occurred.

• Did not include the perspective of children with chronic illness or health care providers, as has been reported in other similar studies.

Comments/Suggestions:

• This study provides a unique context, during the pandemic in Australia, whose incidence of COVID infection and public health measures differed from other countries. Other work exploring this issue in other countries occurred in a context where COVID was more prevalent and school closures were more prolonged, yet the issues identified are similar. (In addition to references cited, see also Nicholas et al, Pediatrics and Child Health, May 2022, https://doi.org/10. 1093/pch/pxab103). This is worth adding to the discussion, particularly to highlight what is unique about this study population compared to others reported in the literature.

• A more detailed explanation of the “Contactless” program alluded to in the discussion would be useful to the reader.

Reviewer #2: Thank you for the opportunity to review your paper which I read with great interest.

This is a robust qualitative paper that requires very little work to make it a paper that I think should be published.

There are some minor issues with punctuation that need to be addressed (see my comments in the attached manuscript re use of full stops with quotations). There are a few instances where an apostrophe is missing in it's.

I think Table 2 should be supplementary material rather than part of the main paper - it's a big table and the quality and comprehensiveness of the quotes already integrated into the text is already sound.

It would have been helpful if the COREQ checklist had been available for cross checking but this may not be a requirement of PLOS ONe.

The figure showing the complexity of overlap with the themes is good but the quality of the image is not great..... text looks fuzzy, so maybe this could be addressed.

Good luck with the paper and I look forward to seeing it published.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-22-14320_reviewer-bc.pdf

PLoS One. 2022 Sep 1;17(9):e0273622. doi: 10.1371/journal.pone.0273622.r002

Author response to Decision Letter 0


4 Aug 2022

Dear Dr Sheperd and Reviewers,

Manuscript ID: PONE-D-22-14320

Title: It’s made a really hard situation even more difficult: The impact of COVID-19 on families of children with chronic illness

We thank the reviewers for taking the time to consdier the above-named manuscript submitted to PLOS One, and for their thoughtful suggestions in the email dated 11th June, 2022. We are grateful for the opportunity to make the suggested amendments and further enhance our manuscript. Please see below for our detailed responses to each of the reviewer’s comments (in bold) and find attached the revised manuscript for your consideration.

Editor’s comments:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

We have reviewed all our files and are confident that they now meet the style requirements of the journal, including file naming.

2. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"The authors acknowledge the support of the Maridulu Budyari Gumal, The Sydney Partnership for Health, Education, Research & Enterprise (SPHERE) Child Unlimited Clinical Academic Group; CEW is supported by the National Health and Medical Research Council of Australia (APP2008300)."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"The author(s) received no specific funding for this work."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Our sincere apologies for this confusion. We have deleted all funding information from the manuscript. In terms of updating the Funding Statement, we would like to acknowledge SPHERE. “The authors acknowledge the support of the Maridulu Budyari Gumal, The Sydney Partnership for Health, Education, Research & Enterprise (SPHERE) Child Unlimited Clinical Academic Group.” Thank you very much for amending this on our behalf.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. We will update your Data Availability statement to reflect the information you provide in your cover letter.

Apologies for not previously providing a Data Availability statement. Given that this research is qualitative in nature, the raw data (i.e. interview transcripts), contain highly sensitive and personal information. This information is medical and personal and refers to children (minors). There is no possible way of deidentifying the data in full due to countless referrals to identifiable information such as the participant’s name, the child’s name, demographic information, the child’s rare disease, the family’s unique situation, the time of year certain events occurred, the school, the hospital, etc. In addition, we are restricted by the relevant ethics committee to not allow access to this data unless expressly named in the approved application. All requests for access to data can be made to either myself, Jordana Mcloone (J.Mcloone@unsw.edu.au) or to the ethics committee, quoting the study reference number: 2020/ETH02434.

The Sydney Children’s Hospital Network Human Research Ethics Committee (SCHN HREC)

Email: SCHN-Ethics@health.nsw.gov.au

Phone +612 9845 1253.

Mail: ‘Research Ethics’ at the Sydney Children’s Hospital Network, Locked Bag 4001, Westmead, 2145, NSW, Australia

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

The reference list has been checked and we are confident all papers are cited correctly.

Reviewer #1:

We would like to thank Reviewer 1 for their kind comments and acknowledgement of the study’s strengths. In response to their “Comments/Suggestions”, we would like to share how we have amended the manuscript to improve upon these aspects.

1. This study provides a unique context, during the pandemic in Australia, whose incidence of COVID infection and public health measures differed from other countries. Other work exploring this issue in other countries occurred in a context where COVID was more prevalent and school closures were more prolonged, yet the issues identified are similar. (In addition to references cited, see also Nicholas et al, Pediatrics and Child Health, May 2022, https://doi.org/10. 1093/pch/pxab103). This is worth adding to the discussion, particularly to highlight what is unique about this study population compared to others reported in the literature.

We thank you for bringing this paper to our attention and have included this reference in our manuscript, as well as alluding to your greater point about the similarity of themes, despite the differences in context.

“Despite experiencing lower levels of COVID-19 than many other parts of the world, especially during 2020, disruptions to health, education and social support have had an acute psychosocial impact on Australian families of children with chronic illness. These themes of mental health impact, feelings of loneliness and isolation, and changes to organisations and policies shaped by COVID-19, have been similarly identified among other populations where COVID-19 was more prevalent and school closures more prolonged (1) Adequately responding to and addressing the needs of families of children with chronic illness, as well as planning for the minimization of longer-term impacts om well-being is critical.”

2. A more detailed explanation of the “Contactless” program alluded to in the discussion would be useful to the reader.

Thank you for this helpful suggestion. We have added some additional information about Contactless, which does not do such a complex project justice, but will at least allow readers to appreciate its model as they read.

“Comprehensive models that offer a number of services, increase in complexity as needed, and address needs from diagnosis to disease progression and long-term care are required. Such programs are beginning to emerge, including Contactless (25), which specifically addresses the care needs of pediatric patients with rare and chronic conditions, who typically need regular follow-up even in the absence of acute events. Contactless is a multimodal, multidisciplinary remote-care model with a modular framework allowing basic care, with escalation on need, up to the more accurate and complex levels of care (2).”

Reviewer #2:

We would also like to thank Reviewer 2 for their insightful comments and suggestions.

1. There are some minor issues with punctuation that need to be addressed (see my comments in the attached manuscript re use of full stops with quotations). There are a few instances where an apostrophe is missing in it's.

We sincerely thank Reviewer 2 for taking the time to make such detailed edits on the manuscript. We have transferred and amended each of these edit notes to the track-changed version and clean version of the revised manuscript, and ran a search of all the it/it’s throughout the manuscript paying close attention to ensure we captured and revised each instance.

2. I think Table 2 should be supplementary material rather than part of the main paper - it's a big table and the quality and comprehensiveness of the quotes already integrated into the text is already sound.

We agree and have confirmed with the journal that this is their preference also. Table 2 is now included as Supplementary material.

3. It would have been helpful if the COREQ checklist had been available for cross checking but this may not be a requirement of PLOS ONe.

We have checked with the journal and they communicated that this is not a requirement as you suggested may be the case. However, we have made a reference to the COREQ in the methods section.

“We used the COREQ (19) checklist to promote accurate reporting of qualitative studies.”

4. The figure showing the complexity of overlap with the themes is good but the quality of the image is not great..... text looks fuzzy, so maybe this could be addressed.

We have checked this thoroughly and used the journal’s image enhancer software to obtain the greatest quality possible for the image. We have also flagged this with the journal and asked that their formatting and production team work with the image to achieve the best possible clarity.

Good luck with the paper and I look forward to seeing it published.

I hope you will agree that we have adequately addressed the queries raised by the reviewers. Should you have any further questions, please do not hesitate to contact.

Thank you for considering our revised manuscript. We look forward to your response.

Regards,

Jordana MdLoone

Decision Letter 1

Stephane Shepherd

12 Aug 2022

It’s made a really hard situation even more difficult: The impact of COVID-19 on families of children with chronic illness

PONE-D-22-14320R1

Dear Dr. McLoone,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Stephane Shepherd, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Stephane Shepherd

23 Aug 2022

PONE-D-22-14320R1

It’s made a really hard situation even more difficult: The impact of COVID-19 on families of children with chronic illness

Dear Dr. McLoone:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Stephane Shepherd

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. The perceived impact of COVID-19—illustrative quotations of longer length.

    (DOCX)

    Attachment

    Submitted filename: PONE-D-22-14320_reviewer-bc.pdf

    Data Availability Statement

    Data cannot be shared publicly in order to uphold the confidentiality of participants who have shared confidential medical information pertaining to children. In addition, we are restricted by the relevant ethics committee to not allow access to this data unless expressly named in the approved application. All requests for access to data can be made to either Jordana Mcloone (J.Mcloone@unsw.edu.au) or to the ethics committee, quoting the study reference number: 2020/ETH02434. The Sydney Children’s Hospital Network Human Research Ethics Committee (SCHN HREC) Email: SCHN-Ethics@health.nsw.gov.au Phone +612 9845 1253. Mail: ‘Research Ethics’ at the Sydney Children’s Hospital Network, Locked Bag 4001, Westmead, 2145, NSW, Australia.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES